Pacific Edge
Dunedin
About Pacific Edge
Pacific Edge is a cancer diagnostics company. They specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Their products are built from their proprietary genetic databases, which are used to identify diagnostic and prognostic biomarkers for cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $83.8K
- Funding stage: IPO
- Last round: Grant (Jul 2024)
- Ticker: nze:PEB
- Website: pacificedgedx.com
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/pacific-edge-2228904 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.